Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

doi:10.1084/jem.182.2.477

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Suzuki, T.
	Articles by Lotze, M. T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Suzuki, T.
	Articles by Lotze, M. T.


Social Bookmarking

	What's this?

ARTICLES

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors

T Suzuki, H Tahara, S Narula, KW Moore, PD Robbins and MT Lotze
Department of Surgery, School of Medicine, University of Pittsburgh, Pennsylvania 15261, USA.

After the cloning of murine cytokine synthesis inhibitory factor, it was recognized that a homologous open reading frame was encoded within the Epstein-Barr virus (human herpes virus 4). This viral protein has now been termed viral interleukin 10 (vIL-10) to reflect its protein sequence homology to "cellular" IL-10 (cIL-10, either murine or human IL-10). It is now widely accepted that vIL-10 shares many functions with cIL-10, principally, the ability to enhance survival of newly infected B cells and to diminish the production of IFN-gamma and IL-2 during ongoing immune reactions. The immunomodulatory effect of locally secreted vIL-10 and murine IL-10 (mIL-10) was examined in tumor models using CL8-1 (a BL6 melanoma cell line transfected with the H-2Kb class I gene) in syngeneic animals. Although parental BL6 tumor cells grow in immunocompetent syngeneic hosts, CL8-1 are rejected. To achieve local secretion of vIL-10, we generated vIL-10 retroviral vectors. While nontransduced CL8-1 cells (1 x 10(4)) failed to grow when injected intradermally in C57BL/6 mice, CL8-1 cells (1 x 10(4)) transduced with vIL-10 formed palpable tumors and eventually killed 80% of injected animals. Suppression of tumor rejection was also noted when CL8-1 tumors with or without vIL-10 transfection were admixed with syngeneic vIL-10-transfected fibroblasts and inoculated. Since the in vitro proliferation of the tumor was not altered after transduction with the vIL-10 gene and injection of vIL-10-transduced CL8-1 does not affect the rejection of nontransduced CL8-1 inoculated at a distant site, local vIL-10 secretion appears to suppress the process of immune rejection of the target cells in a dose-dependent manner. Similar results were observed for the H-2b MCA105 sarcoma tumor model in allogeneic BALB/c mice (H-2d). Although all animals that received nontransfected MCA105 rapidly rejected these tumors, MCA105 sarcomas transfected with vIL-10 remained palpable for up to 37 d. The local immunosuppressive effect of gene-delivered vIL-10 could be neutralized by anti-human IL-10 monoclonal antibody or could be reversed by the systemic administration of IL-2 or IL-12. In marked contrast, mIL-10 transfection of CL8-1 significantly suppressed tumor growth and frequently led to the rejection of tumor. Similar results were obtained for the murine tumor cell lines MCA102.(ABSTRACT TRUNCATED AT 400 WORDS)
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Mangeney, M., Renard, M., Schlecht-Louf, G., Bouallaga, I., Heidmann, O., Letzelter, C., Richaud, A., Ducos, B., Heidmann, T. (2007). Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc. Natl. Acad. Sci. USA 104: 20534-20539 [Abstract] [Full Text]
Zhou, H., Luo, Y., Kaplan, C. D., Kruger, J. A., Lee, S.-H., Xiang, R., Reisfeld, R. A. (2006). A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor. Blood 107: 3251-3257 [Abstract] [Full Text]
Burgess, A., Buck, M., Krauer, K., Sculley, T. (2006). Nuclear localization of the Epstein-Barr virus EBNA3B protein.. J. Gen. Virol. 87: 789-793 [Abstract] [Full Text]
Mocellin, S., Marincola, F. M., Young, H. A. (2005). Interleukin-10 and the immune response against cancer: a counterpoint. J. Leukoc. Biol. 78: 1043-1051 [Abstract] [Full Text]
Zhou, H., Luo, Y., Lo, J.-f., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J.-D., Primus, F. J., Becker, J. C., Xiang, R., Reisfeld, R. A. (2005). DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor. Proc. Natl. Acad. Sci. USA 102: 10846-10851 [Abstract] [Full Text]
Lucas, A., McFadden, G. (2004). Secreted Immunomodulatory Viral Proteins as Novel Biotherapeutics. J. Immunol. 173: 4765-4774 [Abstract] [Full Text]
Kurte, M., Lopez, M., Aguirre, A., Escobar, A., Aguillon, J. C., Charo, J., Larsen, C. G., Kiessling, R., Salazar-Onfray, F. (2004). A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells. J. Immunol. 173: 1731-1737 [Abstract] [Full Text]
Giordani, L., Bruzzi, P., Lasalandra, C., Quaranta, M., Schittulli, F., Della Ragione, F., Iolascon, A. (2003). Association of Breast Cancer and Polymorphisms of Interleukin-10 and Tumor Necrosis Factor-{alpha} Genes. Clin. Chem. 49: 1664-1667 [Full Text]
Herling, M., Rassidakis, G. Z., Medeiros, L. J., Vassilakopoulos, T. P., Kliche, K.-O., Nadali, G., Viviani, S., Bonfante, V., Giardini, R., Chilosi, M., Kittas, C., Gianni, A. M., Bonadonna, G., Pizzolo, G., Pangalis, G. A., Cabanillas, F., Sarris, A. H. (2003). Expression of Epstein-Barr Virus Latent Membrane Protein-1 in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin's Lymphoma: Associations with Presenting Features, Serum Interleukin 10 Levels, and Clinical Outcome. Clin. Cancer Res. 9: 2114-2120 [Abstract] [Full Text]
Ruan, S., Tate, C., Lee, J. J., Ritter, T., Kolls, J. K., Shellito, J. E. (2002). Local Delivery of the Viral Interleukin-10 Gene Suppresses Tissue Inflammation in Murine Pneumocystis carinii Infection. Infect. Immun. 70: 6107-6113 [Abstract] [Full Text]
Wirths, S., Reichert, J., Grunebach, F., Brossart, P. (2002). Activated CD8+ T Lymphocytes Induce Differentiation of Monocytes to Dendritic Cells and Restore the Stimulatory Capacity of Interleukin 10-treated Antigen-presenting Cells. Cancer Res. 62: 5065-5068 [Abstract] [Full Text]
Imlach, W., McCaughan, C. A., Mercer, A. A., Haig, D., Fleming, S. B. (2002). Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J. Gen. Virol. 83: 1049-1058 [Abstract] [Full Text]
Ding, Y., Qin, L., Zamarin, D., Kotenko, S. V., Pestka, S., Moore, K. W., Bromberg, J. S. (2001). Differential IL-10R1 Expression Plays a Critical Role in IL-10-Mediated Immune Regulation. J. Immunol. 167: 6884-6892 [Abstract] [Full Text]
Hammond-McKibben, D., Lake, P., Zhang, J., Tart-Risher, N., Hugo, R., Weetall, M. (2001). A High-Capacity Quantitative Mouse Model of Drug-Mediated Immunosuppression Based on Rejection of an Allogeneic Subcutaneous Tumor. J. Pharmacol. Exp. Ther. 297: 1144-1151 [Abstract] [Full Text]
Kawamoto, S., Nitta, Y., Tashiro, F., Nakano, A., Yamato, E., Tahara, H., Tabayashi, K., Miyazaki, J.-i. (2001). Suppression of Th1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. Int Immunol 13: 685-694 [Abstract] [Full Text]
Qin, L., Ding, Y., Tahara, H., Bromberg, J. S. (2001). Viral IL-10-Induced Immunosuppression Requires Th2 Cytokines and Impairs APC Function Within the Allograft. J. Immunol. 166: 2385-2393 [Abstract] [Full Text]
Brossart, P., Zobywalski, A., Grünebach, F., Behnke, L., Stuhler, G., Reichardt, V. L., Kanz, L., Brugger, W. (2000). Tumor Necrosis Factor {{alpha}} and CD40 Ligand Antagonize the Inhibitory Effects of Interleukin 10 on T-Cell Stimulatory Capacity of Dendritic Cells. Cancer Res. 60: 4485-4492 [Abstract] [Full Text]
Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P., Cannon, M. J. (2000). Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes. J. Virol. 74: 4729-4737 [Abstract] [Full Text]
Knappe, A., Hör, S., Wittmann, S., Fickenscher, H. (2000). Induction of a Novel Cellular Homolog of Interleukin-10, AK155, by Transformation of T Lymphocytes with Herpesvirus Saimiri. J. Virol. 74: 3881-3887 [Abstract] [Full Text]
Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97: 1695-1700 [Abstract] [Full Text]
Ding, Y., Qin, L., Kotenko, S. V., Pestka, S., Bromberg, J. S. (2000). A Single Amino Acid Determines the Immunostimulatory Activity of Interleukin 10. J. Exp. Med. 191: 213-224 [Abstract] [Full Text]
Sharma, S., Stolina, M., Lin, Y., Gardner, B., Miller, P. W., Kronenberg, M., Dubinett, S. M. (1999). T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function. J. Immunol. 163: 5020-5028 [Abstract] [Full Text]
Hashimoto, W., Osaki, T., Okamura, H., Robbins, P. D., Kurimoto, M., Nagata, S., Lotze, M. T., Tahara, H. (1999). Differential Antitumor Effects of Administration of Recombinant IL-18 or Recombinant IL-12 Are Mediated Primarily by Fas-Fas Ligand- and Perforin-Induced Tumor Apoptosis, Respectively. J. Immunol. 163: 583-589 [Abstract] [Full Text]
Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J., Enk, A. H. (1999). Interleukin-10-Treated Human Dendritic Cells Induce a Melanoma-Antigen-Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells. Blood 93: 1634-1642 [Abstract] [Full Text]
Groux, H., Cottrez, F., Rouleau, M., Mauze, S., Antonenko, S., Hurst, S., McNeil, T., Bigler, M., Roncarolo, M.-G., Coffman, R. L. (1999). A Transgenic Model to Analyze the Immunoregulatory Role of IL-10 Secreted by Antigen-Presenting Cells. J. Immunol. 162: 1723-1729 [Abstract] [Full Text]
Mangeney, M., Heidmann, T. (1998). Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc. Natl. Acad. Sci. USA 95: 14920-14925 [Abstract] [Full Text]
Balcewicz-Sablinska, M. K., Keane, J., Kornfeld, H., Remold, H. G. (1998). Pathogenic Mycobacterium tuberculosis Evades Apoptosis of Host Macrophages by Release of TNF-R2, Resulting in Inactivation of TNF-{alpha}. J. Immunol. 161: 2636-2641 [Abstract] [Full Text]
Ma, Y., Thornton, S., Duwel, L. E., Boivin, G. P., Giannini, E. H., Leiden, J. M., Bluestone, J. A., Hirsch, R. (1998). Inhibition of Collagen-Induced Arthritis in Mice by Viral IL-10 Gene Transfer. J. Immunol. 161: 1516-1524 [Abstract] [Full Text]
Apparailly, F., Verwaerde, C., Jacquet, C., Auriault, C., Sany, J., Jorgensen, C. (1998). Adenovirus-Mediated Transfer of Viral IL-10 Gene Inhibits Murine Collagen-Induced Arthritis. J. Immunol. 160: 5213-5220 [Abstract] [Full Text]
Fowler, D. H., Whitfield, B., Livingston, M., Chrobak, P., Gress, R. E. (1998). Non-Host-Reactive Donor CD8+ T Cells of Tc2 Phenotype Potently Inhibit Marrow Graft Rejection. Blood 91: 4045-4050 [Abstract] [Full Text]
Gojo, S., Niwaya, K., Taniguchi, S., Nishizaki, K., Kitamura, S. (1998). Gene Transfer Into the Donor Heart During Cold Preservation for Heart Transplantation. Ann. Thorac. Surg. 65: 647-652 [Abstract] [Full Text]
Osaki, T., Peron, J.-M., Cai, Q., Okamura, H., Robbins, P. D., Kurimoto, M., Lotze, M. T., Tahara, H. (1998). IFN-{gamma}-Inducing Factor/IL-18 Administration Mediates IFN-{gamma}- and IL-12-Independent Antitumor Effects. J. Immunol. 160: 1742-1749 [Abstract] [Full Text]
Arcasoy, S. M., Latoche, J., Gondor, M., Watkins, S. C., Henderson, R. A., Hughey, R., Finn, O. J., Pilewski, J. M. (1997). MUC1 and Other Sialoglycoconjugates Inhibit Adenovirus-mediated Gene Transfer to Epithelial Cells. Am. J. Respir. Cell Mol. Bio. 17: 422-435 [Abstract] [Full Text]
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., Moore, K. W., Kronenberg, M. (1997). Altered Immune Responses in Interleukin 10�Transgenic Mice. J. Exp. Med. 185: 2101-2110 [Abstract] [Full Text]